Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Cunningham

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2003
False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in ThailandPhilip Cunningham, Deborah Marriott, Claire Harris, et al.
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
Thrombosis and Haemostasis|August 3, 2002
Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytesJulia Humphries, Kevin G Burnand, Philip Cunningham, et al.
The International Journal on Drug Policy|July 10, 2020
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapyJenny Iversen, Gregory J Dore, Mitchell Starr, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2019
Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spotsBeth Catlett, Alex Carrera, Mitchell Starr, et al.
Archives of Disease in Childhood|November 5, 2010
Development of a clinical algorithm to prioritise HIV testing of hospitalised paediatric patients in a low resource moderate prevalence settingWaridibo E Allison, Mobumo Kiromat, John Vince, et al.
British Journal of Pharmacology|September 13, 2003
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1Richard J Naftalin, Iram Afzal, Philip Cunningham, et al.
Journal of Virological Methods|November 26, 2021
A multi-center study comparing the analytical sensitivity and clinical concordance of three HIV-1 viral load assaysSergio Carmona, Lucia Hans, Merlin Njoya, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 22, 2012
Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shockManasi Nandi, Peter Kelly, Belen Torondel, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2003
False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in ThailandPhilip Cunningham, Deborah Marriott, Claire Harris, et al.
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
Thrombosis and Haemostasis|August 3, 2002
Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytesJulia Humphries, Kevin G Burnand, Philip Cunningham, et al.
The International Journal on Drug Policy|July 10, 2020
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapyJenny Iversen, Gregory J Dore, Mitchell Starr, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2019
Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spotsBeth Catlett, Alex Carrera, Mitchell Starr, et al.
Archives of Disease in Childhood|November 5, 2010
Development of a clinical algorithm to prioritise HIV testing of hospitalised paediatric patients in a low resource moderate prevalence settingWaridibo E Allison, Mobumo Kiromat, John Vince, et al.
British Journal of Pharmacology|September 13, 2003
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1Richard J Naftalin, Iram Afzal, Philip Cunningham, et al.
Journal of Virological Methods|November 26, 2021
A multi-center study comparing the analytical sensitivity and clinical concordance of three HIV-1 viral load assaysSergio Carmona, Lucia Hans, Merlin Njoya, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 22, 2012
Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shockManasi Nandi, Peter Kelly, Belen Torondel, et al.
Pageof 6